Leaders in cancer research and cancer care have issued a call to action for physicians, parents and young adults to increase vaccination rates to eliminate HPV-related cancers.
Tag: uva cancer center (Page 6)
The Clinical Research Forum recognized Daniel Trey Lee, MD, for his efforts to genetically modify a patient’s own immune cells to identify and kill cancer cells.
A recipient of the 2016 Rising Star in Oncology award from the Society for Translational Medicine, Reilley has set his sights on improving the future of cancer care through clinical trials.
New ACR Appropriateness Criteria added unprecedented depth to what had been a much more modest overview, providing physicians an easy way to catch up with the latest developments and stay at the very forefront of best practices.
Women with dense or homogeneous dense breast tissue should consider an alternate form of breast cancer screening beyond traditional mammography.
In a specialty in which pinpoint accuracy, judgment and timing are paramount, SRS is increasingly considered one of the more promising treatments for especially challenging tumors.
As part of its ongoing mission to expand and optimize its clinical research infrastructure and provide patients access to the most advanced cancer treatment and prevention strategies available, UVA Cancer Center welcomes two world-class clinicians and researchers to grow its bone marrow transplant program.
Each clinic location is staffed with a highly skilled team of oncology-certified nurses, support nurses and phlebotomists, and a medical oncologist is always on-site.
A UVA study revealed that most women don’t know that having dense breast tissue increases their risk for cancer and reduces a mammogram’s ability to detect it.
An expert in immunotherapy, Lawrence G. Lum, MD, DSc joins UVA Cancer Center as the scientific director of bone marrow transplantation. One of Lum’s priorities is pioneering a new method of activating the body’s own T cells to target tumor cells.